about
An unusual native tricuspid valve endocarditis caused by Candida colliculosaComparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis.[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].Transmission route and reasons for HIV testing among recently diagnosed HIV patients in HIV-TR cohort, 2011-2012.Outcomes of initial antiretroviral treatment (ART) among recently diagnosed HIV patients in HIV-TR cohort, 2011-2012.Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.Crimean-Congo hemorrhagic fever in TurkeyHIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran--a prospective multicenter point prevalence study.Risk factors, characteristics, and outcomes of candidemia in an adult intensive care unit in Turkey.Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections.Complete heart block in a neutropenic patient with invasive aspergillosis.Impact of the fluoroquinolones on gastrointestinal flora.Miliary Tuberculosis Induced Acute Liver Failure.Successful treatment of an invasive fungal infection caused by Talaromyces sp. with voriconazoleGiant Purulent Pericarditis with Cardiac Tamponade Due to Streptococcus intermedius Rapidly Progressing to Constriction.Transmitted antiretroviral drug resistance mutations in newly diagnosed HIV-1 positive patients in Turkey.Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate.The features of infectious diseases departments and anti-infective practices in France and Turkey: a cross-sectional study.Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine.Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment.Antimicrobial prophylaxis in management of urinary tract stones by extracorporeal shock-wave lithotripsy: is it necessary?Clinical microbiological case: chronic disseminated candidiasis unresponsive to treatment.Susceptibility of bacterial isolates from Turkey--a report from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program.Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program.Comparison of Risk Category Predictions of Framingham Risk Score (FRS), Atherosclerotic Cardiovascular Disease Risk Score (ASCVD), Systematic Coronary Risk Evaluation (SCORE) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) in HIV InfTreatment of intracranial abscesses: experience with sulbactam/ampicillin.DU-6859a, a new fluoroquinolone agent. Comparative in vitro activity against enteric pathogens and multiresistant outpatient Escherichia coli.[Prevalence of HIV infection in Turkey and importance of cardiovascular disease].Therapy for shigellosis.Subcutaneous nodules caused by Pseudomonas aeruginosa: healing without incision and drainage[Group B streptococcal endocarditis][Shigella serotypes and drug resistance patterns of strains isolated in Etimesgut, Turkey, in 1987]Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococciTreatment of systemic neonatal candidiasis with fluconazoleClostridium difficile acquisition rate and its role in nosocomial diarrhoea at a university hospital in TurkeyBactericidal activity of the fluoroquinolone DU-6859a alone and in combination with other antimicrobial agents against multiresistant enterococciLung abscess due to coexisting Mycobacterium tuberculosis and anaerobic bacteria in a cavitary bronchogenic carcinomaDisseminated Flavimonas oryzihabitans infection in a diabetic patient who presented with suspected multiple splenic abscesses
P50
Q28187592-AF71CED0-E028-4AA1-90D2-EC83A946E257Q33751682-95F80A1A-1546-400B-A786-661E305A13D5Q33758823-F6140B39-639E-4E81-B583-9F0E27D2E442Q33924125-A746807F-8EB3-4F60-A27C-80AF358FFC7DQ34475180-8FCF2F13-9322-4F23-A029-FE2F314DAC17Q34477300-22B25652-3ED5-44F7-AC6C-650881FE8D79Q35064413-F4F4CF76-4ED0-457F-8250-4E80F4D88233Q35873244-6896C33C-1233-4D44-B0E9-F0C47BB50855Q36406860-896AFA91-69A9-4781-9827-AD80256E23AEQ38994488-F02153CD-B952-4835-A8C0-D13F9D1EF90FQ40266372-B95D678E-C458-49DB-B5B5-F392F7C533C9Q40358195-641ACA22-C853-4C7C-8C7E-BC7D9D5E9223Q40463322-86E51B1B-1A30-456F-8ED4-9EDA2F2F48E3Q40489384-D9386FF0-FFBA-4EE8-A43F-0DCC267AF525Q40966673-77F5C541-8E4A-43D4-9055-B875BE5E5D22Q41364724-E9235187-8F80-4ACC-9EEB-834F97AED37AQ41452710-811103DD-8A28-4869-91C8-91CB38B83FDEQ41661579-EA8EF0DE-147B-4F6A-A6E7-7DFBE10621B0Q41732707-B17E1EC7-478A-46F7-827E-72F32E49F5F4Q42216950-5F4D5653-27B6-46EA-98D9-BAFDB72EADAEQ43102684-C8554D88-3282-4807-A268-0E9D6D79C71AQ43284120-C97AB82F-FEC0-43ED-A76A-E54F5088387AQ43942306-E0B197A4-C870-4F69-8704-424564276D81Q44117354-D192A917-B768-4B73-9C43-289C9FAC15E7Q46784473-B4670D45-BDE1-4530-9794-CE279CC56E4FQ46987181-0E2B2C9F-ED65-4A9F-BEAD-45A664D5923CQ47133440-0481F689-AFFF-4DAE-8170-49E8C97EC4CDQ48273374-B21191B5-0852-443C-8222-A7E2E95016F6Q54196161-55713102-BCBD-4950-89B2-C96D099BA410Q54296004-9A0ED1B3-4529-429D-ABDD-09133C41BCDBQ54349820-5C4F4685-7C89-4515-A73A-5FB0C1C74DD4Q67558811-FEC9B36A-A2DF-4320-93CD-CFE13315F728Q68677428-B5331CC8-D966-4ECA-AB6C-3EAB62A780CDQ70273116-812CE783-EC98-49E2-B549-0478FFE732ECQ71071331-2A3CA8E0-A64A-4FBE-B8F7-CBE79788279CQ71131120-BF39FD8B-CB5C-432B-965E-B885BCC9F5E2Q71725920-29D532DE-1757-40B4-B10B-2124D5210E44Q71950322-EB23F638-A8BA-4720-B682-3F67C2ED6B01Q72312057-FBED20C5-CD5E-4AB0-B63F-680025FFB04FQ73793598-F7D70ADF-DF71-432B-ABAF-64EA95C58465
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Volkan Korten
@ast
Volkan Korten
@en
Volkan Korten
@es
Volkan Korten
@nl
type
label
Volkan Korten
@ast
Volkan Korten
@en
Volkan Korten
@es
Volkan Korten
@nl
prefLabel
Volkan Korten
@ast
Volkan Korten
@en
Volkan Korten
@es
Volkan Korten
@nl
P106
P1153
6701848019
P31
P496
0000-0002-9991-814X